Arbeitspapier
Pharmaceutical Prices: The Impact of the Launch Strategy - An Analysis of German Data
This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers' launch strategy (freely chosen first year price) still has a major impact on pricing while the impact of the additional benefit remains comparably small. Moreover, the data suggest that the assessment of the Federal Joint Committee - while not yet existing at the point - best explains the manufacturer's launch strategy, indicating that manufacturers know more than they reveal.
- Sprache
-
Englisch
- Erschienen in
-
Series: CESifo Working Paper ; No. 7879
- Klassifikation
-
Wirtschaft
Health: General
- Thema
-
AMNOG
early benefit
assessment
pharmaceuticals
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Böhler, Yvonne-Beatrice
Lamping, Christian
Wichardt, Philipp C.
- Ereignis
-
Veröffentlichung
- (wer)
-
Center for Economic Studies and ifo Institute (CESifo)
- (wo)
-
Munich
- (wann)
-
2019
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:45 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Böhler, Yvonne-Beatrice
- Lamping, Christian
- Wichardt, Philipp C.
- Center for Economic Studies and ifo Institute (CESifo)
Entstanden
- 2019
Ähnliche Objekte (12)
Pharmaceutical prices : The impact of the launch strategy. An analysis of German data
Pharmaceutical prices: The impact of the launch strategy. An analysis of German data
The launch of the Leviathan
The Launch.
Corporate governance and firm strategy in the pharmaceutical industry
Poetry and reality about the future of the Union: reflections on the demensions and nature of the re-launch of the Lisbon strategy
Economics of the pharmaceutical industry
The launch of a new generation of the ICSID Rules
Launch of The "Louisa Shelbourne" at Battersea
Launch of The "Phoebe", at Devenport dockyard
The launch of Euro notes and coins
The atlas of space rocket launch sites
Pharmaceutical prices : The impact of the launch strategy. An analysis of German data
Pharmaceutical prices: The impact of the launch strategy. An analysis of German data
The launch of the Leviathan
The Launch.
Corporate governance and firm strategy in the pharmaceutical industry
Poetry and reality about the future of the Union: reflections on the demensions and nature of the re-launch of the Lisbon strategy
Economics of the pharmaceutical industry
The launch of a new generation of the ICSID Rules
Launch of The "Louisa Shelbourne" at Battersea
Launch of The "Phoebe", at Devenport dockyard
The launch of Euro notes and coins
The atlas of space rocket launch sites
Pharmaceutical prices : The impact of the launch strategy. An analysis of German data
Pharmaceutical prices: The impact of the launch strategy. An analysis of German data
The launch of the Leviathan
The Launch.
Corporate governance and firm strategy in the pharmaceutical industry
Poetry and reality about the future of the Union: reflections on the demensions and nature of the re-launch of the Lisbon strategy
Economics of the pharmaceutical industry
The launch of a new generation of the ICSID Rules
Launch of The "Louisa Shelbourne" at Battersea
Launch of The "Phoebe", at Devenport dockyard
The launch of Euro notes and coins